Laurie J. Hall Trustee’s Cytokinetics CYTK Stock Holding History

Laurie J. Hall Trustee’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-105	Closed	-$5K	–	271
2022 Q4	$5K	Sell	105 -65	-38%	-$2.8K	﹤0.01%	252
2022 Q3	$8K	Sell	170 -80	-32%	-$3.85K	﹤0.01%	255
2022 Q2	$10K	Hold	250	–	–	﹤0.01%	262
2022 Q1	$9K	Buy	250 +10	+4%	+$355	﹤0.01%	281
2021 Q4	$11K	Hold	240	–	–	﹤0.01%	271
2021 Q3	$9K	Sell	240 -150	-38%	-$4.42K	﹤0.01%	280
2021 Q2	$8K	Hold	390	–	–	﹤0.01%	290
2021 Q1	$9K	Hold	390	–	–	﹤0.01%	290
2020 Q4	$8K	Hold	390	–	–	﹤0.01%	287
2020 Q3	$8K	Buy	+390	New	+$9.12K	﹤0.01%	276
2019 Q4	$3K	Buy	270 +50	+23%	+$514	﹤0.01%	313
2019 Q3	$3K	Hold	220	–	–	﹤0.01%	302
2019 Q2	$2K	Hold	220	–	–	﹤0.01%	319
2019 Q1	$2K	Hold	220	–	–	﹤0.01%	324
2018 Q4	$2K	Sell	220 -50	-19%	-$367	﹤0.01%	322
2018 Q3	$3K	Hold	270	–	–	﹤0.01%	340
2018 Q2	$2K	Hold	270	–	–	﹤0.01%	347
2018 Q1	$2K	Hold	270	–	–	﹤0.01%	347
2017 Q4	$2K	Sell	270 -120	-31%	-$1.36K	﹤0.01%	350
2017 Q3	$5.66K	Buy	+390	New	+$5.33K	﹤0.01%	277

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Laurie J. Hall Trustee's CYTK Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 105 shares — an estimated $5K sold.

Laurie J. Hall Trustee first reported a position in CYTK in Q3 2017 and held it in 20 quarters. The position peaked at $11K in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

Laurie J. Hall Trustee reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
Laurie J. Hall Trustee sold 105 Cytokinetics shares in Q1 2023, an estimated $5K.
Laurie J. Hall Trustee first reported a position in Cytokinetics in Q3 2017 and held it in 20 quarters.
Laurie J. Hall Trustee's Cytokinetics position peaked at $11K in Q4 2021.
262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.